| scholarly article | Q13442814 |
| P2093 | author name string | David Landman | |
| John Quale | |||
| Simona Bratu | |||
| P2860 | cites work | Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae | Q24550605 |
| Extended-spectrum beta-lactamases in Klebsiella pneumoniae bloodstream isolates from seven countries: dominance and widespread prevalence of SHV- and CTX-M-type beta-lactamases | Q24650618 | ||
| Multidrug efflux pumps of gram-negative bacteria | Q24681708 | ||
| Carbapenemases: the versatile beta-lactamases | Q24685034 | ||
| A porin from Klebsiella pneumoniae: sequence homology, three-dimensional model, and complement binding | Q30193612 | ||
| Outer membrane profiles of clonally related Klebsiella pneumoniae isolates from clinical samples and activities of cephalosporins and carbapenems. | Q33694016 | ||
| Development of resistance during antimicrobial therapy caused by insertion sequence interruption of porin genes | Q33976721 | ||
| Roles of beta-lactamases and porins in activities of carbapenems and cephalosporins against Klebsiella pneumoniae | Q33977146 | ||
| Identification and characterization of a new porin gene of Klebsiella pneumoniae: its role in beta-lactam antibiotic resistance | Q33991864 | ||
| Outbreak of Klebsiella pneumoniae producing a new carbapenem-hydrolyzing class A beta-lactamase, KPC-3, in a New York Medical Center | Q34370760 | ||
| Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City: a new threat to our antibiotic armamentarium | Q34429494 | ||
| In vivo selection of porin-deficient mutants of Klebsiella pneumoniae with increased resistance to cefoxitin and expanded-spectrum-cephalosporins. | Q35122321 | ||
| Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC beta-lactamase, and the foss of an outer membrane protein. | Q35133558 | ||
| Carbapenem resistance in Klebsiella pneumoniae not detected by automated susceptibility testing | Q35793289 | ||
| Role of Klebsiella pneumoniae OmpK35 porin in antimicrobial resistance. | Q36047378 | ||
| Characterization of a large outbreak by CTX-M-1-producing Klebsiella pneumoniae and mechanisms leading to in vivo carbapenem resistance development | Q38471723 | ||
| High-level carbapenem resistance in a Klebsiella pneumoniae clinical isolate is due to the combination of bla(ACT-1) beta-lactamase production, porin OmpK35/36 insertional inactivation, and down-regulation of the phosphate transport porin phoe | Q38665541 | ||
| Emergence of Serratia marcescens, Klebsiella pneumoniae, and Escherichia coli Isolates possessing the plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC-2 in intensive care units of a Chinese hospital. | Q38899499 | ||
| Expression of SHV-2 beta-lactamase and of reduced amounts of OmpK36 porin in Klebsiella pneumoniae results in increased resistance to cephalosporins and carbapenems. | Q39657843 | ||
| Role of beta-lactamases and porins in resistance to ertapenem and other beta-lactams in Klebsiella pneumoniae | Q41269079 | ||
| Emergence of KPC-possessing Klebsiella pneumoniae in Brooklyn, New York: epidemiology and recommendations for detection | Q42054277 | ||
| Evaluation of methods to identify the Klebsiella pneumoniae carbapenemase in Enterobacteriaceae | Q42413051 | ||
| Detection and spread of Escherichia coli possessing the plasmid-borne carbapenemase KPC-2 in Brooklyn, New York | Q44904821 | ||
| In vivo development of ertapenem resistance in a patient with pneumonia caused by Klebsiella pneumoniae with an extended-spectrum beta-lactamase | Q46435439 | ||
| Porin expression in clinical isolates of Klebsiella pneumoniae | Q47969611 | ||
| Emergence of imipenem resistance in Klebsiella pneumoniae owing to combination of plasmid-mediated CMY-4 and permeability alteration. | Q54027871 | ||
| Activity of nine antimicrobial agents against clinical isolates of Klebsiella pneumoniae producing extended-spectrum beta-lactamases and deficient or not in porins | Q73149848 | ||
| Ertapenem resistance among Klebsiella and Enterobacter submitted in the UK to a reference laboratory | Q79757213 | ||
| Evolution of antimicrobial resistance among Pseudomonas aeruginosa, Acinetobacter baumannii and Klebsiella pneumoniae in Brooklyn, NY | Q80301574 | ||
| P433 | issue | Pt 10 | |
| P921 | main subject | Klebsiella pneumoniae | Q132592 |
| carbapenem antibiotic | Q410897 | ||
| P304 | page(s) | 1303-1308 | |
| P577 | publication date | 2009-06-25 | |
| P1433 | published in | Journal of Medical Microbiology | Q15708716 |
| P1476 | title | Contribution of OmpK36 to carbapenem susceptibility in KPC-producing Klebsiella pneumoniae | |
| P478 | volume | 58 |
| Q36276987 | A swordless knight: epidemiology and molecular characteristics of the blaKPC-negative sequence type 258 Klebsiella pneumoniae clone |
| Q38956254 | Accuracy of carbapenem nonsusceptibility for identification of KPC-possessing Enterobacteriaceae by use of the revised CLSI breakpoints |
| Q89592886 | Activity of Cefiderocol Against Enterobacterales, Pseudomonas aeruginosa, and Acinetobacter baumannii Endemic to Medical Centers in New York City |
| Q40283492 | Activity of Imipenem with Relebactam against Gram-Negative Pathogens from New York City |
| Q40284963 | Activity of Meropenem Combined with RPX7009, a Novel β-Lactamase Inhibitor, against Gram-Negative Clinical Isolates in New York City |
| Q90701875 | Activity of Meropenem with a Novel Broader-Spectrum β-Lactamase Inhibitor, WCK 4234, against Gram-Negative Pathogens Endemic to New York City |
| Q47604376 | Activity of Simulated Human Dosage Regimens of Meropenem and Vaborbactam against Carbapenem-Resistant Enterobacteriaceae in an In Vitro Hollow-Fiber Model. |
| Q38049220 | Adaptive and mutational resistance: role of porins and efflux pumps in drug resistance. |
| Q37797732 | Alarming β-lactamase-mediated resistance in multidrug-resistant Enterobacteriaceae |
| Q46172822 | Assessment of antimicrobial combinations for Klebsiella pneumoniae carbapenemase-producing K. pneumoniae |
| Q40125157 | Biofilm formation and antibiotic resistance in Klebsiella pneumoniae urinary strains. |
| Q37894832 | Broad-specificity efflux pumps and their role in multidrug resistance of Gram-negative bacteria |
| Q42878619 | Carbapenem and cefoxitin resistance of Klebsiella pneumoniae strains associated with porin OmpK36 loss and DHA-1 β-lactamase production |
| Q38392082 | Carbapenemase-producing Gram-negative bacteria: current epidemics, antimicrobial susceptibility and treatment options |
| Q36361921 | Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions |
| Q41818495 | Characteristics of meropenem heteroresistance in Klebsiella pneumoniae carbapenemase (KPC)-producing clinical isolates of K. pneumoniae |
| Q36785877 | Characterization of porin expression in Klebsiella pneumoniae Carbapenemase (KPC)-producing K. pneumoniae identifies isolates most susceptible to the combination of colistin and carbapenems. |
| Q37135034 | Citrobacter freundii carrying blaKPC-2 and blaNDM-1: characterization by whole genome sequencing |
| Q41809654 | Comparison of meropenem MICs and susceptibilities for carbapenemase-producing Klebsiella pneumoniae isolates by various testing methods |
| Q42929741 | Comparison of the activity of a human simulated, high-dose, prolonged infusion of meropenem against Klebsiella pneumoniae producing the KPC carbapenemase versus that against Pseudomonas aeruginosa in an in vitro pharmacodynamic model |
| Q37544774 | Contribution of β-lactamases and porin proteins OmpK35 and OmpK36 to carbapenem resistance in clinical isolates of KPC-2-producing Klebsiella pneumoniae |
| Q42145477 | Detection of OqxAB efflux pumps, OmpK35 and OmpK36 porins in extended-spectrum-β-lactamase-producing Klebsiella pneumoniae isolates from Iran |
| Q41576384 | Detection of β -Lactamases and Outer Membrane Porins among Klebsiella pneumoniae Strains Isolated in Iran. |
| Q90151752 | Development of a Two Triplex Real-Time Polymerase Chain Reaction for Rapid Detection of Six Carbapenemase Genes in Enterobacteriaceae |
| Q33797981 | Doripenem, gentamicin, and colistin, alone and in combinations, against gentamicin-susceptible, KPC-producing Klebsiella pneumoniae strains with various ompK36 genotypes |
| Q35860134 | Effect of Resistance Mechanisms on the Inoculum Effect of Carbapenem in Klebsiella pneumoniae Isolates with Borderline Carbapenem Resistance |
| Q40392497 | Emergence of Ceftazidime-Avibactam Resistance Due to Plasmid-Borne blaKPC-3 Mutations during Treatment of Carbapenem-Resistant Klebsiella pneumoniae Infections |
| Q39868076 | Emergence of bla KPC-3-Tn4401a associated with a pKPN3/4-like plasmid within ST384 and ST388 Klebsiella pneumoniae clones in Spain |
| Q34483491 | Evaluation of ceftazidime and NXL104 in two murine models of infection due to KPC-producing Klebsiella pneumoniae |
| Q34151206 | Genetic factors associated with elevated carbapenem resistance in KPC-producing Klebsiella pneumoniae |
| Q52609077 | Genomic Analysis of a Pan-Resistant Isolate of Klebsiella pneumoniae, United States 2016. |
| Q37119944 | Global Dissemination of blaKPC into Bacterial Species beyond Klebsiella pneumoniae and In Vitro Susceptibility to Ceftazidime-Avibactam and Aztreonam-Avibactam |
| Q38306504 | Global dissemination of extensively drug-resistant carbapenemase-producing Enterobacteriaceae: clinical perspectives on detection, treatment and infection control |
| Q49549766 | In vitro and in vivo activity of single and dual antimicrobial agents against KPC-producing Klebsiella pneumoniae |
| Q42881737 | In vitro potency of various polymyxin B components |
| Q40766720 | Inactivation or inhibition of AcrAB-TolC increases resistance of carbapenemase-producing Enterobacteriaceae to carbapenems |
| Q38002916 | Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae: a review of epidemiological and clinical aspects |
| Q26828604 | Mechanisms of resistance and clinical relevance of resistance to β-lactams, glycopeptides, and fluoroquinolones |
| Q46306375 | Meropenem-Vaborbactam Resistance Selection, Resistance Prevention, and Molecular Mechanisms in Mutants of KPC-Producing Klebsiella pneumoniae |
| Q24628782 | Molecular diversity in mechanisms of carbapenem resistance in paediatric Enterobacteriaceae |
| Q37263324 | Mutations of the ompK36 porin gene and promoter impact responses of sequence type 258, KPC-2-producing Klebsiella pneumoniae strains to doripenem and doripenem-colistin. |
| Q40342720 | New Polymyxin B Dosing Strategies To Fortify Old Allies in the War against KPC-2-Producing Klebsiella pneumoniae. |
| Q35297743 | Non-phenotypic tests to detect and characterize antibiotic resistance mechanisms in Enterobacteriaceae |
| Q38626877 | OmpK26, a novel porin associated with carbapenem resistance in Klebsiella pneumoniae. |
| Q43530672 | OmpK35 and OmpK36 porin variants associated with specific sequence types of Klebsiella pneumoniae |
| Q35208845 | Outbreak of multidrug resistant NDM-1-producing Klebsiella pneumoniae from a neonatal unit in Shandong Province, China |
| Q40616155 | Predictability of Phenotype in Relation to Common β-Lactam Resistance Mechanisms in Escherichia coli and Klebsiella pneumoniae. |
| Q48326742 | Prevalence of extended-spectrum beta-lactamase and carbapenemase-producing bloodstream isolates of Klebsiella pneumoniae in a tertiary care hospital. |
| Q37322284 | Promoter deletions of Klebsiella pneumoniae carbapenemase (KPC)-encoding genes (blaKPC -2) and efflux pump (AcrAB) on β-lactam susceptibility in KPC-producing Enterobacteriaceae |
| Q35607909 | Rapid induction of high-level carbapenem resistance in heteroresistant KPC-producing Klebsiella pneumoniae |
| Q30356154 | Rapid susceptibility profiling of carbapenem-resistant Klebsiella pneumoniae. |
| Q35682579 | Risk factors for carbapenem-resistant Klebsiella pneumoniae infection/colonization and predictors of mortality: a retrospective study |
| Q36172541 | Role of ISKpn7 and deletions in blaKPC gene expression |
| Q36174574 | Stepwise evolution of pandrug-resistance in Klebsiella pneumoniae |
| Q42638031 | Vaborbactam: Spectrum of Beta-Lactamase Inhibition and Impact of Resistance Mechanisms on Activity in Enterobacteriaceae |
| Q42000829 | bla(KPC) RNA expression correlates with two transcriptional start sites but not always with gene copy number in four genera of Gram-negative pathogens |
Search more.